Bring them up with your healthcare provider, especially if you experience: Sustained low mood or loss of interest lasting more than two weeks Increased anxiety or panic episodes that werent present before treatment Unusual irritability or emotional reactivity that interferes with daily life Thoughts of self-harm or suicide (seek immediate help
Personalised approach to weight management As with any medical intervention, the response to Ozempic, retatrutide, and other weight loss medications can vary among individuals
Expansion of coverage under Medicare of GLP-1s to treat obesity under the BALANCE model is likely to increase utilization above current levels, as Medicare begins to meet the demand for obesity drugs among beneficiaries who have been unable to access or afford these medications to date
Meta-analyses have also highlighted that GLP-1RAs are linked to modest reductions in total cholesterol, LDL-c, and triglycerides [58]
Theories About Why Dual Action Works Better Scientists are still working to fully understand why adding GIP agonism to GLP-1 agonism creates such substantial additional benefits
WeightWatchers also is moving into the obesity drug market with its recent acquisition of telehealth company Sequence for $132 million
